These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 37489366)
1. Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization. Cruz Amaya J; Walcheck B; Smith-Gagen J; Lombardi VC; Hudig D Antibodies (Basel); 2023 Jun; 12(3):. PubMed ID: 37489366 [TBL] [Abstract][Full Text] [Related]
2. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells. Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954 [TBL] [Abstract][Full Text] [Related]
3. Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC). Tang JJ; Sung AP; Guglielmo MJ; Navarrete-Galvan L; Redelman D; Smith-Gagen J; Hudig D Antibodies (Basel); 2020 Oct; 9(4):. PubMed ID: 33081115 [TBL] [Abstract][Full Text] [Related]
4. Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells. Hullsiek R; Li Y; Snyder KM; Wang S; Di D; Borgatti A; Lee C; Moore PF; Zhu C; Fattori C; Modiano JF; Wu J; Walcheck B Front Immunol; 2022; 13():841859. PubMed ID: 35281028 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells. Rodriguez Benavente MC; Hughes HB; Kremer PG; Subedi GP; Barb AW Immunology; 2023 Oct; 170(2):202-213. PubMed ID: 37218360 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers. Liao B; Tumanut C; Li L; Corper A; Challa D; Chang A; Begum H; Farokhi E; Woods C; Fan X MAbs; 2024; 16(1):2381261. PubMed ID: 39048914 [TBL] [Abstract][Full Text] [Related]
7. Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells. Karampatzakis A; Brož P; Rey C; Önfelt B; Cruz De Matos GDS; Rycroft D; Ambrose A; Davis DM Front Immunol; 2021; 12():641521. PubMed ID: 33796107 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines. Park JE; Kim SE; Keam B; Park HR; Kim S; Kim M; Kim TM; Doh J; Kim DW; Heo DS J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32830112 [TBL] [Abstract][Full Text] [Related]
9. Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity. van Hauten PMM; Hooijmaijers L; Vidal-Manrique M; van der Waart AB; Hobo W; Wu J; Blijlevens NMA; Jansen JH; Walcheck B; Schaap NPM; de Jonge PKJD; Dolstra H Cytotherapy; 2024 Mar; 26(3):252-260. PubMed ID: 38127030 [TBL] [Abstract][Full Text] [Related]
10. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. Mata MM; Mahmood F; Sowell RT; Baum LL J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308 [TBL] [Abstract][Full Text] [Related]
11. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC. Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548 [TBL] [Abstract][Full Text] [Related]
12. Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy. Nikkhoi SK; Li G; Eleya S; Yang G; Vandavasi VG; Hatefi A Front Immunol; 2022; 13():1039969. PubMed ID: 36685519 [TBL] [Abstract][Full Text] [Related]
13. From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. Coënon L; Villalba M Front Immunol; 2022; 13():913215. PubMed ID: 35720368 [TBL] [Abstract][Full Text] [Related]